Rapafusyn Pharma Secures $44M Series A Funding for Molecular
04 Sep 2025 //
GLOBENEWSWIRE
Rapafusyn Pharma Showcases Molecular Glue Platform At WuXi Forum
08 Jan 2025 //
GLOBENEWSWIRE
Rapafusyn to Present at Targeted Protein Degradation Summit
23 Oct 2024 //
GLOBENEWSWIRE
Rapafusyn To Present In Vivo Data On ENT1 Inhibitor At ASN 2024
17 Oct 2024 //
GLOBENEWSWIRE